Mega Lifesciences PCL (BKK:MEGA) ROCE % : 30.32% (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Mega Lifesciences PCL's annualized ROCE % for the quarter that ended in Dec. 2024 was 30.32%.

Mega Lifesciences PCL ROCE % Historical Data

The historical data trend for Mega Lifesciences PCL's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL ROCE % Chart

Mega Lifesciences PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

24.74

29.28

29.94

24.40

23.93

Mega Lifesciences PCL Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															22.57	22.08	23.91	18.76	30.32

Mega Lifesciences PCL ROCE % Calculation

Mega Lifesciences PCL's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	2390.677	/	( ( (14114.858 - 4426.568)	+	(14210.134 - 3914.314) )	/ 2 )
	=	2390.677	/	( (9688.29	+	10295.82)	/ 2 )
	=	2390.677	/	9992.055
	=	23.93 %

Mega Lifesciences PCL's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	3023.408	/	( ( (13532.761 - 3885.959)	+	(14210.134 - 3914.314) )	/ 2 )
	=	3023.408	/	( ( 9646.802	+	10295.82 )	/ 2 )
	=	3023.408	/	9971.311
	=	30.32 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Mega Lifesciences PCL (BKK:MEGA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Mega Lifesciences PCL ROCE % Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mega Lifesciences PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

MEGA-R:Thailand

Address

Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260

Website

https://www.megawecare.com

Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines